Pfizer's New Breast Cancer Drug Wins FDA Approval, Pioneering PROTAC Therapy
VEPPANU (vepdegestrant), co-developed by Pfizer and Arvinas, has received U.S. FDA approval for the treatment of specifi…
🏷️ PROTAC
1 articles about 'PROTAC'
1